Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D FROHLICH

Showing results (31-40 of 361) with videos related to

Pageof 37
Sort By:
Annals of Epidemiology|May 1, 1991
Obesity and hypertension. Hemodynamic aspectsE D Frohlich
Hypertension (Dallas, Tex. : 1979)|February 1, 1988
The heart in hypertension: unresolved conceptual challenges. Special lectureE D Frohlich
Cardiology Clinics|February 1, 1986
Left ventricular hypertrophy as a risk factorE D Frohlich
Hypertension (Dallas, Tex. : 1979)|May 1, 1989
Angiotensin converting enzyme inhibitors. Present and futureE D Frohlich
Hypertension (Dallas, Tex. : 1979)|February 1, 1988
Clinical pharmacology of calcium antagonists. Satellite symposium on calcium antagonistsE D Frohlich
Journal of Cardiovascular Pharmacology|January 1, 1991
Regression of cardiac hypertrophy and left ventricular pumping ability postregressionE D Frohlich
The American Journal of Cardiology|December 6, 1985
Hemodynamic effects of calcium entry-blocking agents in normal and hypertensive rats and manE D Frohlich
The Medical Clinics of North America|October 6, 1997
Current clinical pathophysiologic considerations in essential hypertensionE D Frohlich
Mayo Clinic Proceedings|June 1, 1977
The adrenergic nervous system and hypertension state of the artE D Frohlich
Cardiovascular Drugs and Therapy|December 1, 1989
Life's quality: a major consideration in health care delivery--especially with hypertensive diseasesE D Frohlich
Pageof 37

Showing results (31-40 of 361) with videos related to

Sort By:
Pageof 37
Annals of Epidemiology|May 1, 1991
Obesity and hypertension. Hemodynamic aspectsE D Frohlich
Hypertension (Dallas, Tex. : 1979)|February 1, 1988
The heart in hypertension: unresolved conceptual challenges. Special lectureE D Frohlich
Cardiology Clinics|February 1, 1986
Left ventricular hypertrophy as a risk factorE D Frohlich
Hypertension (Dallas, Tex. : 1979)|May 1, 1989
Angiotensin converting enzyme inhibitors. Present and futureE D Frohlich
Hypertension (Dallas, Tex. : 1979)|February 1, 1988
Clinical pharmacology of calcium antagonists. Satellite symposium on calcium antagonistsE D Frohlich
Journal of Cardiovascular Pharmacology|January 1, 1991
Regression of cardiac hypertrophy and left ventricular pumping ability postregressionE D Frohlich
The American Journal of Cardiology|December 6, 1985
Hemodynamic effects of calcium entry-blocking agents in normal and hypertensive rats and manE D Frohlich
The Medical Clinics of North America|October 6, 1997
Current clinical pathophysiologic considerations in essential hypertensionE D Frohlich
Mayo Clinic Proceedings|June 1, 1977
The adrenergic nervous system and hypertension state of the artE D Frohlich
Cardiovascular Drugs and Therapy|December 1, 1989
Life's quality: a major consideration in health care delivery--especially with hypertensive diseasesE D Frohlich
Pageof 37